Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Liquidia Corp (LQDA)

Liquidia Corp (LQDA)
14.04 +0.01 (+0.07%) 11:35 ET [NASDAQ]
14.03 x 27 14.07 x 8
Realtime by (Cboe BZX)
14.03 x 27 14.07 x 8
Realtime 14.08 +0.05 (+0.36%) 09:19 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Liquidia Corp 419 DAVIS DRIVE SUITE 100 MORRISVILLE NC 27560 USA

www.liquidia.com Employees: 170 P: 919-328-4400 F: 919-328-4402

Sector:

Medical

Description:

Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,196,745
Enterprise Value, $K 1,135,655
Shares Outstanding, K 85,299
Annual Sales, $ 14,000 K
Annual Net Income, $ -130,390 K
Last Quarter Sales, $ 2,920 K
Last Quarter Net Income, $ -38,370 K
EBIT, $ -121,300 K
EBITDA, $ -119,100 K
60-Month Beta 0.23
% of Insider Shareholders 30.10%
% of Institutional Shareholders 64.54%
Float, K 59,624
% Float 69.90%
Short Volume Ratio 0.53

Growth:

1-Year Return 13.82%
3-Year Return 157.90%
5-Year Return 173.49%
5-Year Revenue Growth 73.48%
5-Year Earnings Growth 37.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.46 on 03/19/25
Next Earnings Date 05/12/25 [--]
Earnings Per Share ttm -1.74
EPS Growth vs. Prev Qtr -24.32%
EPS Growth vs. Prev Year -9.52%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LQDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -161.64%
Return-on-Assets % -63.47%
Profit Margin % -931.36%
Debt/Equity 1.49
Price/Sales 82.58
Price/Cash Flow N/A
Price/Book 14.84
Book Value/Share 0.91
Interest Coverage -9.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective